Mij
Senior Member (Voting Rights)
Scientists created a supercharged form of vitamin K that could help the brain regrow lost neurons and fight diseases like Alzheimer's
Date: May 27, 2026
Source: Shibaura Institute of Technology
Summary: Scientists in Japan have created powerful new vitamin K-based compounds that may help the brain regenerate lost neurons — a breakthrough that could one day change how diseases like Alzheimer’s and Parkinson’s are treated. By combining vitamin K with components related to vitamin A, the researchers developed compounds that were about three times more effective at turning neural stem cells into neurons than natural vitamin K alone.
Why the Finding Matters
The work highlights a possible route toward therapies that do more than manage symptoms. By pushing neural progenitor cells toward becoming neurons, vitamin K based compounds could one day contribute to strategies aimed at slowing, delaying, or potentially reversing parts of neurodegeneration.
That remains a long term goal. The findings are based on cell studies and mouse experiments, not human trials. No vitamin K derived drug has yet been shown to repair the brains of people with Alzheimer's, Parkinson's, or Huntington's disease. Still, the results give researchers a clearer target, especially the mGluR1 pathway, for developing future brain repair therapies.
Study
Date: May 27, 2026
Source: Shibaura Institute of Technology
Summary: Scientists in Japan have created powerful new vitamin K-based compounds that may help the brain regenerate lost neurons — a breakthrough that could one day change how diseases like Alzheimer’s and Parkinson’s are treated. By combining vitamin K with components related to vitamin A, the researchers developed compounds that were about three times more effective at turning neural stem cells into neurons than natural vitamin K alone.
Why the Finding Matters
The work highlights a possible route toward therapies that do more than manage symptoms. By pushing neural progenitor cells toward becoming neurons, vitamin K based compounds could one day contribute to strategies aimed at slowing, delaying, or potentially reversing parts of neurodegeneration.
That remains a long term goal. The findings are based on cell studies and mouse experiments, not human trials. No vitamin K derived drug has yet been shown to repair the brains of people with Alzheimer's, Parkinson's, or Huntington's disease. Still, the results give researchers a clearer target, especially the mGluR1 pathway, for developing future brain repair therapies.
Study